| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |